Market Access for Medical Technologies in Denmark

In December 2025, the Danish Health Data Authority published the DRG tariff system (Takstsystem) guide, which provides an overall description of billing rules, tariffs, and grouping logic for 2026. Among other changes, 17 new DRGs were introduced in the nephrology and urology, obstetrics and gynecology, and some other fields.

In December 2025, the Danish Healthcare Quality Institute (DHQI) released a methodological document clarifying the processes of health economic analyses associated with the clinical guidelines and the DHQI Council’s decision-making. Furthermore, the first two health economic analyses associated with the clinical guidelines were published concerning prostate-specific membrane antigen (PSMA)-PET/CT in prostate cancer and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.

In December 2025, the Danish Health Data Authority published the DRG tariffs for 2026. In accordance with the released documentation, one new DRG will be introduced in 2026.